ImmunityBioIBRX 
$3.423.01%24h
3.01%24h
Global rank4750
Market cap$2.29B
Change 7d-4.47%
YTD Performance-31.46%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Category
Market capitalization of ImmunityBio (IBRX)
As of November 2024, ImmunityBio has a market cap of $2.29B. This makes ImmunityBio the world's 4750th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of ImmunityBio from 2015 to 2024
-
Value:-
Market cap history of ImmunityBio from 2015 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $3.16B | -6.18% |
| 2023 | $3.37B | -0.99% |
| 2022 | $3.40B | -16.61% |
| 2021 | $4.08B | -54.39% |
| 2020 | $8.94B | 251.72% |
| 2019 | $2.54B | 226.72% |
| 2018 | $777.58M | -74.16% |
| 2017 | $3.01B | -21.50% |
| 2016 | $3.83B | -66.99% |
| 2015 | $11.62B | - |
IBRX Market Cap Today is $2.29B 3.01% - 21 Nov 2024
View largest stocks by market cap 
